1. Home
  2. TBI vs QNCX Comparison

TBI vs QNCX Comparison

Compare TBI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

N/A

Current Price

$3.74

Market Cap

129.9M

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TBI
QNCX
Founded
1985
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
167.0M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
TBI
QNCX
Price
$3.74
$0.10
Analyst Decision
Buy
Hold
Analyst Count
1
3
Target Price
$6.00
$10.00
AVG Volume (30 Days)
266.0K
67.7M
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.44
$0.09
52 Week High
$7.78
$4.55

Technical Indicators

Market Signals
Indicator
TBI
QNCX
Relative Strength Index (RSI) 36.03 27.93
Support Level $3.44 $0.09
Resistance Level $5.56 $0.98
Average True Range (ATR) 0.25 0.02
MACD -0.00 0.09
Stochastic Oscillator 29.52 21.00

Price Performance

Historical Comparison
TBI
QNCX

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: